-
-
-
-
-
-
-
Portage Biotech Inc. (PRTG) Misses Q2 EPS by 98c
-
-
-
-
-
-
-
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
-
-
-
-
-
-
-
Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022
-
-
-
-
-
-
-
BIOHAVEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS
-
-
-
-
-
-
-
Biohaven Pharma (BHVN), Pfizer (PFE) Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Announces Preliminary 3Q Net Product Revenue For NURTEC ODT
-
-
-
-
-
-
-
Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven
-
976,271 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All